NCT04267588 is a clinical trial of Navio Mobile App in Pain, Chronic, sponsored by Johns Hopkins University.

Who is sponsoring NCT04267588?

NCT04267588 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT04267588?

Interventions in NCT04267588: Navio Mobile App.

What condition does NCT04267588 study?

NCT04267588 studies Pain, Chronic.

Is NCT04267588 still recruiting?

NCT04267588 is currently recruiting now. Last updated 29 June 2025.

Last reviewed 2025-06-29 · How we verify

NCT04267588

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Technology to Track Pain and Pain-related Outcomes

Recruiting now Last updated 29 June 2025

What this trial tests

trial testing Navio Mobile App in Pain, Chronic in 100 participants. Currently enrolling.

Timeline

10 August 2020

Primary endpoint
30 June 2026

30 June 2026

Quick facts

Lead sponsor	Johns Hopkins University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	10 August 2020
Primary completion	30 June 2026
Estimated completion	30 June 2026
Sites	1 location across United States

Drugs / interventions tested

Navio Mobile App

Conditions studied

Pain, Chronic — all drugs for Pain, Chronic →

Sponsor

Johns Hopkins University

Who can join

21 and older, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Persistent pain is a public health epidemic. The current protocol seeks to develop technology to aid patients' tracking of patients' pain, medications and pain-related variables. The investigators seek to talk with patients in co-investigator's clinic to solicit feedback, as well as pilot test the technology with pain patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

NCT06800209 — Pain Reprocessing Therapy in Post-Operative Knee Pain · Phase 2 · recruiting
NCT06512727 — The PROACTIVE Study for Black Elders · NA · recruiting
NCT06837857 — Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain · Phase 2 · recruiting
NCT06541184 — Ziconotide for Non-cancer Pain by Intrathecal Administration · recruiting
NCT06592053 — Affecting Factors for Chronic Pain After Mastectomy · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04267588 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 29 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04267588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing